12:00 – 2:00 pm, March 17th (Friday), 2017

Smith 308/309

Dana-Farber Cancer Institute

450 Brookline Avenue, Boston, MA 02215

Lunch will be provided

About Geneseeq Technology Inc.

Geneseeq is a health solutions company that specializes in personalized cancer care and aims to provide treatment solutions based on the comprehensive analyses of patients’ genomic profile. Since 2008, Geneseeq has employed next generation sequencing (NGS) in the field of clinical translational medicine and precision oncology care, and has established Chinese largest cancer genomic database with over 40,000 clinical samples.

Geneseeq’s Chinese headquarters has over 100,000 ft² of translational medicine center located in Nanjing, Jiangsu province, which is equipped with the entire series of Illumina sequencing platforms including HiSeq X-TEN and upcoming NovaSeq. Our state-of-the-art clinical testing center is accredited by the College of American Pathologists (CAP), and is also certified by Chinese Ministry of Health Clinical Examination Center and European EMQN Proficiency Testing.

Geneseeq now employs approximately 400 people globally, composed of highly trained scientists, technical specialists, sales and marketing personnel. By partnering with over 350 top-tier hospitals and research centers in China, as well as world-leading pharmaceutical companies, we are striving for better targeting therapies and improved life qualities for cancer patients.

Position Offered:

       Oncology/Immunology Scientist (PI, Group leader), R&D Department

       Bioinformatician/Senior Bioinformatic Scientist, Bioinformatic Department

       Project Manager, Medical Department

Location: Nanjing, Jiangsu, China

HR Hotline: +1 6472551075

Email: hr@geneseeq.com

Company website: www.geneseeq.com